This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Sealed Air's rigid medical packaging business was formed from three previous acquisitions: Nelipak Holdings, Alga Plastics and ATE Costa Rica, which includes facilities in each of Ireland, the Netherlands, the United States andCosta Rica.
"The transaction is another step in our commitment to a disciplined approach to portfolio management," said Jerome A. Peribere, President and Chief Executive Officer, Sealed Air. "Our rigid medical business has a strong global position but no longer presents a strategic fit for us. By further focusing our portfolio, we can maximize our investment in new innovations which are core to our market-driven business."
Peribere also said, "Sealed Air remains committed to the medical packaging industry and will continue to manufacture medical and pharmaceutical films."
The transaction is expected to be completed in the fourth quarter of 2013, subject to the satisfaction of customary closing conditions. The price will be subject to certain purchase price adjustments.
On October 30, 2013, the Company provided its full year 2013 outlook for net sales of approximately $7.7 billion and Adjusted EPS to be in the range of $1.25 to $1.30. This outlook included estimated net sales of approximately$100 million and approximately $0.04 earnings per share related to the rigid medical packaging business. The Company expects that the results of this business will be accounted for as discontinued operations. Further details of the impact of this transaction will be presented in the Company's fourth quarter earnings release on February 6, 2014.
